Evidence map›Paper›PMID 24775991›Full record

Trial reportBiological psychiatry2014

Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.

Lorenzo Leggio, William H Zywiak, Samuel R Fricchione, Steven M Edwards, Suzanne M de la Monte, Robert M Swift, George A Kenna

3 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Biological psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 97 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01190085 nacompletednot on this map

Effects of Ghrelin on Alcohol Cue Reactivity and Craving

TypeinterventionalSponsorBrown UniversityRan2011Enrolled45ConditionsAlcoholismArmsGhrelin, Saline solution
NCT01779024 phase2completednot on this map

Effects of Ghrelin on Alcohol Administration in Non-Treatment Seeking Heavy Drinkers

TypeinterventionalSponsorNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Ran2012 to 2017Enrolled17ConditionsfMRI, Alcohol Drinking, AlcoholismArmsGhrelin, Placebo, fMRI, Alcohol
NCT02039349 phase1completednot on this map

A Novel Compound for Alcoholism Treatment: A Translational Strategy

TypeinterventionalSponsorNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Ran2014 to 2017Enrolled14ConditionsAlcoholism, Alcohol-Related Disorders, Alcohol Dependence, Alcohol Drinking Related ProblemsArmsPF-05190457
3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 1 synthesis or guideline pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Acute Effect of Eating Sweets on Alcohol Cravings in a Sample with At-Risk Drinking.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2020
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Lorenzo LeggioSection on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland; Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, Providence. Electronic address: lorenzo.leggio@nih.gov.
William H ZywiakDecision Sciences Institute, Pacific Institute for Research and Evaluation, Pawtucket; Center for Alcohol and Addiction Studies, Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island.
Samuel R FricchioneCenter for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, Providence.
Steven M EdwardsDepartment of Psychology, University of Nebraska-Lincoln, Lincoln, Nebraska.
Suzanne M de la MonteDepartments of Pathology, Neurology, and Neurosurgery, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Robert M SwiftCenter for Alcohol and Addiction Studies, Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island; Veterans Affairs Medical Center, Providence, Rhode Island.
George A KennaCenter for Alcohol and Addiction Studies, Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island.
Brown University · USDecision Sciences (United States) · USNational Institutes of Health · USProvidence College · USUniversity of Nebraska–Lincoln · US

Funding

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)ZIAAA000218 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI LEGGIO, LORENZO · 2013 to 2020
$22.8M
Ethanol, IRS-1 Signaling and Neuronal MigrationR37AA011431 · NIAAA · RHODE ISLAND HOSPITAL · PI DE LA MONTE, SUZANNE M. · 2009 to 2018
$3.7M
Effects of Ghrelin on Alcohol Cue Reactivity and CravingR21AA019709 · NIAAA · BROWN UNIVERSITY · PI KENNA, GEORGE A. · 2010 to 2011
$436k
Intramural NIH HHS ZIA AA000218NIAAA NIH HHS R21 AA019709NIAAA NIH HHS R21-AA019709NIAAA NIH HHS R37 AA011431
6 · The paper itself

Abstract

backgroundThere is a need to identify novel pharmacologic targets to treat alcoholism. Animal and human studies suggest a role for ghrelin in the neurobiology of alcohol dependence and craving. Here, we were the first to test the hypothesis that intravenous administration of exogenous ghrelin acutely increases alcohol craving.

methodsThis was a double-blind, placebo-controlled human laboratory proof-of-concept study. Nontreatment-seeking, alcohol-dependent, heavy-drinking individuals were randomized to receive intravenous ghrelin 1 mcg/kg, 3 mcg/kg or 0 mcg/kg (placebo), followed by a cue-reactivity procedure, during which participants were exposed to neutral (juice) and alcohol cues. The primary outcome variable was the increase in alcohol craving (also called urge) for alcohol, assessed by the Alcohol Visual Analogue Scale.

resultsOut of 103 screenings, 45 individuals received the study drug. Repeated measures of analysis of covariance revealed a group effect across ghrelin doses in increasing alcohol craving (p < .05). A dose-specific examination revealed a significant effect of ghrelin 3 mcg/kg versus placebo in increasing alcohol craving (p < .05) with a large effect size (d = .94). By contrast, no significant ghrelin effect was found in increasing either urge to drink juice or food craving (p = ns). No significant differences in side effects were found (p = ns).

conclusionsIntravenous administration of exogenous ghrelin increased alcohol craving in alcohol-dependent heavy-drinking individuals. Although the small sample requires confirmatory studies, these findings provide preliminary evidence that ghrelin may play a role in the neurobiology of alcohol craving, thus demonstrating a novel pharmacologic target for treatment.

Indexed as

Administration, IntravenousAdultAlcoholismAnalysis of VarianceBlood PressureCravingCuesDose-Response Relationship, DrugDouble-Blind MethodFemaleGhrelinHeart RateHumansMaleMiddle AgedSalivaGhrelinAlcoholismcravingcue-reactivityfeeding peptidesghrelinneuroendocrinology

Identifiers

PMID24775991
PMCPMC4176606
OpenAlexW2028988924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.